Inventor · disambiguated record
Anna Moore
Also filed as: MOORE ANNA · MOORE ANNA V
14 granted patents·12 pending applications·67 citations·filing 2007–2024
89Inventor score
Files withMASSACHUSETTS GEN HOSPITAL11GEN HOSPITAL CORP3UTI LP3MEDAROVA ZDRAVKA2UTI LIMITED PARTNERSHIP2
Top patents by PatentIndex Score
26 records- 0195US8354110B2Compositions and methods for the prevention and treatment of autoimmune conditionsUTI LIMITED PARTNERSHIP·Filed 2008·Granted Jan 15, 2013·36 cites·21 claims
- 0290US9629812B2Therapeutic nanoparticles and methods of use thereofMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Apr 25, 2017·18 cites·18 claims
- 0388US2025121043A1Compositions and methods for the prevention and treatment of autoimmune conditionsUTI LP·Filed 2024·Application pending·0 cites
- 0482US10463627B2Therapeutic nanoparticles and methods of use thereofMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Nov 5, 2019·3 cites·28 claims
- 0577US9763891B2Therapeutic nanoparticles and methods of use thereofMEDAROVA ZDRAVKA·Filed 2012·Granted Sep 19, 2017·4 cites·13 claims
- 0676US2023414790A1miRNA PROFILING COMPOSITIONS AND METHODS OF USEMASSACHUSETTS GEN HOSPITAL·Filed 2023·Application pending·0 cites
- 0774US12138321B2Half-curcuminoids as amyloid-β PET imaging agentsMASSACHUSETTS GEN HOSPITAL·Filed 2021·Granted Nov 12, 2024·0 cites·20 claims
- 0874US12102695B2Half-curcuminoids as amyloid-beta pet imaging agentsMASSACHUSETTS GEN HOSPITAL·Filed 2021·Granted Oct 1, 2024·0 cites·20 claims
- 0974US10086093B2miRNA profiling compositions and methods of useMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Oct 2, 2018·1 cites·18 claims
- 1074US2021145949A1Compositions and methods for the prevention and treatment of autoimmune conditionsUTI LP·Filed 2020·Application pending·0 cites
- 1173US8574914B2Methods for mobile zinc measurementLIPPARD STEPHEN J·Filed 2010·Granted Nov 5, 2013·2 cites·21 claims
- 1269US9738623B2Curcumin analogsMASSACHUSETTS GEN HOSPITAL·Filed 2013·Granted Aug 22, 2017·1 cites·22 claims
- 1369US8563043B2Innately multimodal nanoparticlesMEDAROVA ZDRAVKA·Filed 2010·Granted Oct 22, 2013·1 cites·26 claims
- 1467US10149644B2Curcumin derivatives for amyloid-β plaque imagingMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Dec 11, 2018·1 cites·12 claims
- 1564US11135318B2Half-curcuminoids as amyloid-beta PET imaging agentsMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Oct 5, 2021·0 cites·14 claims
- 1664US2019054195A1Mirna profiling compositions and methods of useMASSACHUSETTS GEN HOSPITAL·Filed 2018·Application pending·0 cites
- 1763US2017333540A1Compositions and methods for the prevention and treatment of autoimmune conditionsUTI LP·Filed 2017·Application pending·0 cites
- 1861US2013302421A1Compositions and methods for the prevention and treatment of autoimmune conditionsGEN HOSPITAL CORP·Filed 2012·Application pending·0 cites
- 1957US2008056998A1Composition and processes for crossing the blood-brain barrier with polypeptides for in vivo neuroimagingGEN HOSPITAL CORP·Filed 2007·Application pending·0 cites
- 2056US2011059121A1Compositions and methods for the prevention and treatment of autoimmune conditionsUTI LIMITED PARTNERSHIP·Filed 2010·Application pending·0 cites
- 2153US2011208064A1Curcumin Derivatives for Amyloid-Beta Plaque ImagingCHONGZHAO RAN·Filed 2009·Application pending·0 cites
- 2252US2022031873A1Multi-Modal Contrast Agent For Medical ImagingUNIV MICHIGAN STATE·Filed 2021·Application pending·0 cites
- 2348US9757477B2Imaging brown adipose tissue with curcumin derivativesMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Sep 12, 2017·0 cites·20 claims
- 2444US2015004711A1Methods and assays relating to prostate cancerGEN HOSPITAL CORP·Filed 2013·Application pending·0 cites
- 2537US2013129579A1Colorimetric method and device for detecting analyte quantities in fluids and materialsMOORE ANNA·Filed 2011·Application pending·0 cites
- 2633US8986657B2Methods and system for detecting soluble amyloid-βRAN CHONGZHAO·Filed 2010·Granted Mar 24, 2015·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Anna Moore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →